Pharmafile Logo

TVF Communications

Novartis building

Canada and Switzerland lift Novartis flu vaccines ban

Independent tests confirm safety following contamination fears

- PMLiVE

Will Boehringer succeed with Syrum?

Time will tell if Boehringer’s bold ambitions for its Facebook game can be fulfilled

- PMLiVE

Roche’s Avastin cleared in EU for recurrent ovarian cancer

Becomes first biologic to win approval for platinum-sensitive ovarian cancer

- PMLiVE

Novo Nordisk posts ‘robust’ gains in sales and earnings

Diabetes drug Victoza and insulin analogue portfolio see strong growth

The Access Partnership hires Mike Mallinson

He joins with more than 30 years’ experience gained both on agency and client-side

Charles River Laboratories acquires Chinese research company

Pays $27m for Beijing-based Vital River

- PMLiVE

Discounts persuade NICE to recommend skin cancer drugs Yervoy and Zelboraf

Roche and BMS offer patient access schemes for NHS use of drugs

Patheon hires Covance’s Michael Lehmann for global pharma role

He joins the contract development and manufacturing company as president of global pharmaceutical development services

- PMLiVE

UK Bribery Act: A game changer

The Director of the Serious Fraud Office intends to enforce the Act ‘vigorously’ – it would be wise to take him at his word

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links